These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27146926)

  • 1. The need for pharmacovigilance in ophthalmic practice.
    Natarajan S
    Indian J Ophthalmol; 2016 Mar; 64(3):175-6. PubMed ID: 27146926
    [No Abstract]   [Full Text] [Related]  

  • 2. Are we pharmacovigilant enough in ophthalmic practice?
    Dubey A; Handu SS
    Indian J Ophthalmol; 2013 May; 61(5):226-9. PubMed ID: 23571233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions due to ophthalmic drugs: Reporting system in India.
    Kalaiselvan V; Mishra P; Singh GN
    Indian J Ophthalmol; 2016 Mar; 64(3):255-6. PubMed ID: 27146948
    [No Abstract]   [Full Text] [Related]  

  • 4. A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India.
    Panja B; Bhowmick S; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sen A; Sarkar M; Ram AK; Mukherjee PK
    Indian J Pharmacol; 2015; 47(1):126-7. PubMed ID: 25821329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adverse Drug Reactions in Ophthalmology--Update 2015/2016].
    Schlote T; Kellner U
    Klin Monbl Augenheilkd; 2016 Feb; 233(2):203-16; quiz 217-99. PubMed ID: 26878736
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacovigilance and use of online health information.
    Masoni M; Guelfi MR; Conti A; Gensini GF
    Trends Pharmacol Sci; 2013 Jul; 34(7):357-8. PubMed ID: 23759353
    [No Abstract]   [Full Text] [Related]  

  • 7. Ophthalmic Drug Discovery and Development.
    Gukasyan HJ; Hailu S; Karami TK
    Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing the care of the obese ophthalmic patient.
    Dansby-Kelly AF
    Insight; 2009; 34(4):14-7; quiz 18. PubMed ID: 20000133
    [No Abstract]   [Full Text] [Related]  

  • 9. [Using nanotechnology and nanomaterials in ophthalmology].
    Zhdanova OV; Chekman IS; Rykov SO
    Lik Sprava; 2010; (5-6):21-30. PubMed ID: 21488365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Editorial: adverse drug reactions].
    Taegtmeyer AB
    Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
    [No Abstract]   [Full Text] [Related]  

  • 11. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.
    Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G;
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance.
    Osakwe A; Oreagba I; Adewunmi AJ; Adekoya A; Fajolu I
    Int J Risk Saf Med; 2013; 25(4):219-27. PubMed ID: 24305560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance in Europe.
    Johnson CL; Hutchinson JA
    Transplantation; 2015 Aug; 99(8):1542-3. PubMed ID: 26308299
    [No Abstract]   [Full Text] [Related]  

  • 15. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
    Krähenbühl S
    Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pharmacovigilance Syndrome.
    Greenblatt DJ
    J Clin Psychopharmacol; 2015 Aug; 35(4):361-3. PubMed ID: 26066340
    [No Abstract]   [Full Text] [Related]  

  • 18. A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria.
    Awodele O; Daniel A; Popoola TD; Salami EF
    Int J Risk Saf Med; 2013; 25(4):205-17. PubMed ID: 24305559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A profile of ophthalmic drug prescribing.
    Burns RP; Chappell SC
    Ophthalmology; 1979 Jan; 86(1):112-4. PubMed ID: 530557
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacovigilance center --internal medicine interactions: A useful diagnostic tool].
    Rochoy M; Gautier S; Bordet R; Caron J; Launay D; Hachulla E; Hatron PY; Lambert M
    Rev Med Interne; 2015 Aug; 36(8):516-21. PubMed ID: 25771174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.